These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 29621648)

  • 1. Integrating phosphoproteomics into kinase-targeted cancer therapies in precision medicine.
    Wu X; Xing X; Dowlut D; Zeng Y; Liu J; Liu X
    J Proteomics; 2019 Jan; 191():68-79. PubMed ID: 29621648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of phosphoproteomics in the development of personalized cancer therapies.
    Cutillas PR
    Proteomics Clin Appl; 2015 Apr; 9(3-4):383-95. PubMed ID: 25488289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphotyrosine-based-phosphoproteomics scaled-down to biopsy level for analysis of individual tumor biology and treatment selection.
    Labots M; van der Mijn JC; Beekhof R; Piersma SR; de Goeij-de Haas RR; Pham TV; Knol JC; Dekker H; van Grieken NCT; Verheul HMW; Jiménez CR
    J Proteomics; 2017 Jun; 162():99-107. PubMed ID: 28442448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent developments in mass spectrometry-based quantitative phosphoproteomics.
    Smith JC; Figeys D
    Biochem Cell Biol; 2008 Apr; 86(2):137-48. PubMed ID: 18443627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalization of prostate cancer therapy through phosphoproteomics.
    Yang W; Freeman MR; Kyprianou N
    Nat Rev Urol; 2018 Aug; 15(8):483-497. PubMed ID: 29752463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical challenges translating mass spectrometry-based phosphoproteomics from discovery to clinical applications.
    Iliuk AB; Arrington JV; Tao WA
    Electrophoresis; 2014 Dec; 35(24):3430-40. PubMed ID: 24890697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative phosphoproteomics--an emerging key technology in signal-transduction research.
    Schreiber TB; Mäusbacher N; Breitkopf SB; Grundner-Culemann K; Daub H
    Proteomics; 2008 Nov; 8(21):4416-32. PubMed ID: 18837465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted mass spectrometry: An emerging powerful approach to unblock the bottleneck in phosphoproteomics.
    Osinalde N; Aloria K; Omaetxebarria MJ; Kratchmarova I
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jun; 1055-1056():29-38. PubMed ID: 28441545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inference of kinase-signaling networks in human myeloid cell line models by Phosphoproteomics using kinase activity enrichment analysis (KAEA).
    Hallal M; Braga-Lagache S; Jankovic J; Simillion C; Bruggmann R; Uldry AC; Allam R; Heller M; Bonadies N
    BMC Cancer; 2021 Jul; 21(1):789. PubMed ID: 34238254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive characterization of the phosphoproteome of gastric cancer from endoscopic biopsy specimens.
    Abe Y; Hirano H; Shoji H; Tada A; Isoyama J; Kakudo A; Gunji D; Honda K; Boku N; Adachi J; Tomonaga T
    Theranostics; 2020; 10(5):2115-2129. PubMed ID: 32089736
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of phosphoproteomics in the translation of kinase-targeted therapies.
    Casado P; Hijazi M; Britton D; Cutillas PR
    Proteomics; 2017 Mar; 17(6):. PubMed ID: 27774731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphoproteomics-Based Profiling of Kinase Activities in Cancer Cells.
    Wirbel J; Cutillas P; Saez-Rodriguez J
    Methods Mol Biol; 2018; 1711():103-132. PubMed ID: 29344887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Direct Kinase Substrates via Kinase Assay-Linked Phosphoproteomics.
    Xue L; Arrington JV; Tao WA
    Methods Mol Biol; 2016; 1355():263-73. PubMed ID: 26584932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances and challenges in plant phosphoproteomics.
    Silva-Sanchez C; Li H; Chen S
    Proteomics; 2015 Mar; 15(5-6):1127-41. PubMed ID: 25429768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quantitation of cellular phosphorylation dynamics by phosphoproteomics approaches].
    Ishihama Y; Imami K
    Yakugaku Zasshi; 2014; 134(4):521-7. PubMed ID: 24694813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphoproteomics in cancer.
    Harsha HC; Pandey A
    Mol Oncol; 2010 Dec; 4(6):482-95. PubMed ID: 20937571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The current state of the art of quantitative phosphoproteomics and its applications to diabetes research.
    Chan CY; Gritsenko MA; Smith RD; Qian WJ
    Expert Rev Proteomics; 2016; 13(4):421-33. PubMed ID: 26960075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A recent update on small-molecule kinase inhibitors for targeted cancer therapy and their therapeutic insights from mass spectrometry-based proteomic analysis.
    Lee PY; Yeoh Y; Low TY
    FEBS J; 2023 Jun; 290(11):2845-2864. PubMed ID: 35313089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of elemental mass spectrometry in phosphoproteomic applications.
    Maes E; Tirez K; Baggerman G; Valkenborg D; Schoofs L; Encinar JR; Mertens I
    Mass Spectrom Rev; 2016; 35(3):350-60. PubMed ID: 25139451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review on recent trends in the phosphoproteomics workflow. From sample preparation to data analysis.
    Urban J
    Anal Chim Acta; 2022 Mar; 1199():338857. PubMed ID: 35227377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.